REVIEW
Published on 03 Dec 2024
Role of rapidly evolving immunotherapy in chronic active Epstein-Barr virus disease
doi 10.3389/fimmu.2024.1451977
- 803 views
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunotherapy: Up to Date Progress in Childhood and Hematological Malignancies
Immunotherapy: Up to Date Progress in Childhood and Hematological Malignancies
3,341
Total downloads
10k
Total views and downloads
Articles
CORRECTION
Published on 07 Feb 2024
Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring
doi 10.3389/fimmu.2024.1373852
- 699 views
ORIGINAL RESEARCH
Published on 16 Jan 2024
Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring
doi 10.3389/fimmu.2023.1280580
- 3,989 views
- 7 citations
CASE REPORT
Published on 17 Nov 2023
Case Report: CD19 and CD20 monoclonal antibodies with sequential chemotherapy for refractory acute B-lymphocytic leukemia in children
doi 10.3389/fimmu.2023.1280759
- 1,485 views
- 1 citation
SYSTEMATIC REVIEW
Published on 16 Feb 2023
The immunotherapy advancement targeting malignant blastomas in early childhood
doi 10.3389/fonc.2023.1015115
- 1,576 views
Published in
Frontiers in Oncology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore